Urine Based Glucose Monitoring - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509249771

Publication Date:

September 11, 2024

Pages:

129

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Urine-based glucose monitoring is a method used to measure glucose levels in urine samples. While not as accurate as blood-based monitoring, urine testing can provide an indication of glucose levels and help in diabetes management.
The global market for Urine Based Glucose Monitoring was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The market for urine-based glucose monitoring is driven by factors such as its simplicity and cost-effectiveness, making it a viable option in certain healthcare settings or resource-limited environments. However, the growing popularity of blood-based and non-invasive glucose monitoring methods may impact the market's growth in the long term.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Urine Based Glucose Monitoring, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Urine Based Glucose Monitoring by region & country, by Type, and by Application.
The Urine Based Glucose Monitoring market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Urine Based Glucose Monitoring.
Market Segmentation
By Company
Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation
Segment by Type:
Wearable Blood Glucose Monitoring Systems
Table Top Blood Glucose Monitoring Systems
Segment by Application
Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Urine Based Glucose Monitoring manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Urine Based Glucose Monitoring in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Urine Based Glucose Monitoring in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 Urine Based Glucose Monitoring Product Introduction
1.2 Global Urine Based Glucose Monitoring Market Size Forecast
1.2.1 Global Urine Based Glucose Monitoring Sales Value (2019-2030)
1.2.2 Global Urine Based Glucose Monitoring Sales Volume (2019-2030)
1.2.3 Global Urine Based Glucose Monitoring Sales Price (2019-2030)
1.3 Urine Based Glucose Monitoring Market Trends & Drivers
1.3.1 Urine Based Glucose Monitoring Industry Trends
1.3.2 Urine Based Glucose Monitoring Market Drivers & Opportunity
1.3.3 Urine Based Glucose Monitoring Market Challenges
1.3.4 Urine Based Glucose Monitoring Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Urine Based Glucose Monitoring Players Revenue Ranking (2023)
2.2 Global Urine Based Glucose Monitoring Revenue by Company (2019-2024)
2.3 Global Urine Based Glucose Monitoring Players Sales Volume Ranking (2023)
2.4 Global Urine Based Glucose Monitoring Sales Volume by Company Players (2019-2024)
2.5 Global Urine Based Glucose Monitoring Average Price by Company (2019-2024)
2.6 Key Manufacturers Urine Based Glucose Monitoring Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Urine Based Glucose Monitoring Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Urine Based Glucose Monitoring
2.9 Urine Based Glucose Monitoring Market Competitive Analysis
2.9.1 Urine Based Glucose Monitoring Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Urine Based Glucose Monitoring Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Urine Based Glucose Monitoring as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Wearable Blood Glucose Monitoring Systems
3.1.2 Table Top Blood Glucose Monitoring Systems
3.2 Global Urine Based Glucose Monitoring Sales Value by Type
3.2.1 Global Urine Based Glucose Monitoring Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Urine Based Glucose Monitoring Sales Value, by Type (2019-2030)
3.2.3 Global Urine Based Glucose Monitoring Sales Value, by Type (%) (2019-2030)
3.3 Global Urine Based Glucose Monitoring Sales Volume by Type
3.3.1 Global Urine Based Glucose Monitoring Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Urine Based Glucose Monitoring Sales Volume, by Type (2019-2030)
3.3.3 Global Urine Based Glucose Monitoring Sales Volume, by Type (%) (2019-2030)
3.4 Global Urine Based Glucose Monitoring Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Others
4.2 Global Urine Based Glucose Monitoring Sales Value by Application
4.2.1 Global Urine Based Glucose Monitoring Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Urine Based Glucose Monitoring Sales Value, by Application (2019-2030)
4.2.3 Global Urine Based Glucose Monitoring Sales Value, by Application (%) (2019-2030)
4.3 Global Urine Based Glucose Monitoring Sales Volume by Application
4.3.1 Global Urine Based Glucose Monitoring Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Urine Based Glucose Monitoring Sales Volume, by Application (2019-2030)
4.3.3 Global Urine Based Glucose Monitoring Sales Volume, by Application (%) (2019-2030)
4.4 Global Urine Based Glucose Monitoring Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Urine Based Glucose Monitoring Sales Value by Region
5.1.1 Global Urine Based Glucose Monitoring Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Urine Based Glucose Monitoring Sales Value by Region (2019-2024)
5.1.3 Global Urine Based Glucose Monitoring Sales Value by Region (2025-2030)
5.1.4 Global Urine Based Glucose Monitoring Sales Value by Region (%), (2019-2030)
5.2 Global Urine Based Glucose Monitoring Sales Volume by Region
5.2.1 Global Urine Based Glucose Monitoring Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Urine Based Glucose Monitoring Sales Volume by Region (2019-2024)
5.2.3 Global Urine Based Glucose Monitoring Sales Volume by Region (2025-2030)
5.2.4 Global Urine Based Glucose Monitoring Sales Volume by Region (%), (2019-2030)
5.3 Global Urine Based Glucose Monitoring Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Urine Based Glucose Monitoring Sales Value, 2019-2030
5.4.2 North America Urine Based Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Urine Based Glucose Monitoring Sales Value, 2019-2030
5.5.2 Europe Urine Based Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Urine Based Glucose Monitoring Sales Value, 2019-2030
5.6.2 Asia Pacific Urine Based Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Urine Based Glucose Monitoring Sales Value, 2019-2030
5.7.2 South America Urine Based Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Urine Based Glucose Monitoring Sales Value, 2019-2030
5.8.2 Middle East & Africa Urine Based Glucose Monitoring Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Urine Based Glucose Monitoring Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Urine Based Glucose Monitoring Sales Value
6.2.1 Key Countries/Regions Urine Based Glucose Monitoring Sales Value, 2019-2030
6.2.2 Key Countries/Regions Urine Based Glucose Monitoring Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Urine Based Glucose Monitoring Sales Value, 2019-2030
6.3.2 United States Urine Based Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Urine Based Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Urine Based Glucose Monitoring Sales Value, 2019-2030
6.4.2 Europe Urine Based Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Urine Based Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Urine Based Glucose Monitoring Sales Value, 2019-2030
6.5.2 China Urine Based Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.5.3 China Urine Based Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Urine Based Glucose Monitoring Sales Value, 2019-2030
6.6.2 Japan Urine Based Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Urine Based Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Urine Based Glucose Monitoring Sales Value, 2019-2030
6.7.2 South Korea Urine Based Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Urine Based Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Urine Based Glucose Monitoring Sales Value, 2019-2030
6.8.2 Southeast Asia Urine Based Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Urine Based Glucose Monitoring Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Urine Based Glucose Monitoring Sales Value, 2019-2030
6.9.2 India Urine Based Glucose Monitoring Sales Value by Type (%), 2023 VS 2030
6.9.3 India Urine Based Glucose Monitoring Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Company Information
7.1.2 Abbott Introduction and Business Overview
7.1.3 Abbott Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abbott Urine Based Glucose Monitoring Product Offerings
7.1.5 Abbott Recent Development
7.2 Medtronic
7.2.1 Medtronic Company Information
7.2.2 Medtronic Introduction and Business Overview
7.2.3 Medtronic Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Medtronic Urine Based Glucose Monitoring Product Offerings
7.2.5 Medtronic Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Introduction and Business Overview
7.3.3 Roche Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Roche Urine Based Glucose Monitoring Product Offerings
7.3.5 Roche Recent Development
7.4 Bayer AG
7.4.1 Bayer AG Company Information
7.4.2 Bayer AG Introduction and Business Overview
7.4.3 Bayer AG Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bayer AG Urine Based Glucose Monitoring Product Offerings
7.4.5 Bayer AG Recent Development
7.5 B. Braun
7.5.1 B. Braun Company Information
7.5.2 B. Braun Introduction and Business Overview
7.5.3 B. Braun Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.5.4 B. Braun Urine Based Glucose Monitoring Product Offerings
7.5.5 B. Braun Recent Development
7.6 Nipro Diagnostics
7.6.1 Nipro Diagnostics Company Information
7.6.2 Nipro Diagnostics Introduction and Business Overview
7.6.3 Nipro Diagnostics Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Nipro Diagnostics Urine Based Glucose Monitoring Product Offerings
7.6.5 Nipro Diagnostics Recent Development
7.7 Life Scan Inc.(J&J)
7.7.1 Life Scan Inc.(J&J) Company Information
7.7.2 Life Scan Inc.(J&J) Introduction and Business Overview
7.7.3 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Life Scan Inc.(J&J) Urine Based Glucose Monitoring Product Offerings
7.7.5 Life Scan Inc.(J&J) Recent Development
7.8 Arkray Devices
7.8.1 Arkray Devices Company Information
7.8.2 Arkray Devices Introduction and Business Overview
7.8.3 Arkray Devices Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Arkray Devices Urine Based Glucose Monitoring Product Offerings
7.8.5 Arkray Devices Recent Development
7.9 Nova Biomedical
7.9.1 Nova Biomedical Company Information
7.9.2 Nova Biomedical Introduction and Business Overview
7.9.3 Nova Biomedical Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Nova Biomedical Urine Based Glucose Monitoring Product Offerings
7.9.5 Nova Biomedical Recent Development
7.10 Bionime Corporation
7.10.1 Bionime Corporation Company Information
7.10.2 Bionime Corporation Introduction and Business Overview
7.10.3 Bionime Corporation Urine Based Glucose Monitoring Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Bionime Corporation Urine Based Glucose Monitoring Product Offerings
7.10.5 Bionime Corporation Recent Development
8 Industry Chain Analysis
8.1 Urine Based Glucose Monitoring Industrial Chain
8.2 Urine Based Glucose Monitoring Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Urine Based Glucose Monitoring Sales Model
8.5.2 Sales Channel
8.5.3 Urine Based Glucose Monitoring Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Abbott
Medtronic
Roche
Bayer AG
B. Braun
Nipro Diagnostics
Life Scan Inc.(J&J)
Arkray Devices
Nova Biomedical
Bionime Corporation

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂